TABLE 1 Relationship between E-Cadherin Expression, ER, PR, and HER2/neu Status in IBC versus Non-IBC Patients

From: Persistent E-Cadherin Expression in Inflammatory Breast Cancer

 

IBC: # of Positive Cases (%)

Non-IBC: # of Positive Cases (%)

P Value

E-cadherin expression

20 (100)

15 (68)

=.006

ER expression

7 (41)

8 (38)

>.05

PR expression

6 (35)

9 (43)

>.05

HER2/neu overexpression

5 (56)

6 (43)

>.05

  1. ER, estrogen receptor; PR, progesterone receptors; IBC, inflammatory breast cancer; non-IBC, non–inflammatory breast cancer.
Back to article page